Recommendations for inclusion in the Authorisation List
Recommendations for inclusion in the Authorisation List
Nested Applications
The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV (the "Authorisation List") to the European Commission, taking into account comments received from interested parties and the opinion of the Member State Committee. The European Commission finally decides, which substances will be included in Annex XIV and what the associated entries will be.
The below table includes all Candidate List substances that have been included in ECHA's draft or final recommendations for inclusion in Annex XIV. The "Status"- column indicates whether the substances have been included in a draft recommendation, recommended for inclusion or are already included in Annex XIV. Further details and documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.
Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds along with the other substances on the Candidate List. They may be included in future recommendations. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
- Consultation on draft recommendation for inclusion in the Authorisation List
- MSC recommendation opinions
- Recommendation for inclusion in the Authorisation List under the Legislation section
- Authorisation Process
- Recommendation to amend authorisation list entries
- Candidate List of SVHCs for authorisation
- Authorisation List
Recommendations for inclusion in the Authorisation List
Last updated 20 listopada 2023. Database contains 111 unique substances/entries.
show/hide
|
799-969-7
|
-
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
231-100-4
|
7439-92-1
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
203-856-5
|
111-30-8
|
Respiratory sensitising properties (Article 57(f) - human health) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
203-468-6
|
107-15-3
|
Respiratory sensitising properties (Article 57(f) - human health) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
276-090-2
|
71850-09-4
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
show/hide
|
799-970-2
|
-
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
262-967-7
|
61788-32-7
|
vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
209-136-7
|
556-67-2
|
PBT (Article 57d) vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
208-762-8
|
540-97-6
|
PBT (Article 57d) vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
234-541-0
|
12008-41-2
|
Toxic for reproduction (Article 57c) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
201-545-9
|
84-61-7
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
208-764-9
|
541-02-6
|
PBT (Article 57d) vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
209-008-0
|
552-30-7
|
Respiratory sensitising properties (Article 57(f) - human health) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
235-252-2
|
12141-20-7
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
215-290-6
|
1319-46-6
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
201-075-4
|
78-00-2
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
263-467-1
|
62229-08-7
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
EC No.:
939-460-0
| CAS No.:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
EC No.:
300-298-5
| CAS No.:
93925-00-9
|
-
|
-
|
Endocrine disrupting properties (Article 57(f) - environment) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details |
915-270-3
|
-
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
234-853-7
|
12036-76-9
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details |
292-966-7
|
91031-62-8
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
235-702-8
|
12578-12-0
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details |
273-688-5
|
69011-06-9
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
201-245-8
|
80-05-7
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
209-218-2
|
561-41-1
|
Carcinogenic (Article 57a) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
203-713-7
|
109-86-4
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
239-622-4
|
15571-58-1
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
203-804-1
|
110-80-5
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC No.:
-
| CAS No.:
135821-03-3
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EC No.:
236-948-9
| CAS No.:
13560-89-9
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC No.:
-
| CAS No.:
135821-74-8
|
-
|
-
|
vPvB (Article 57e) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details |
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
EC No.:
413-720-9
| CAS No.:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
601-499-3
| CAS No.:
117933-89-8
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
-
| CAS No.:
186309-28-4
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
EC No.:
-
| CAS No.:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
EC No.:
-
| CAS No.:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-02-5
|
-
|
-
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details |
223-346-6
|
3846-71-7
|
PBT (Article 57d) vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
253-037-1
|
36437-37-3
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
247-384-8
|
25973-55-1
|
PBT (Article 57d) vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
223-383-8
|
3864-99-1
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
212-828-1
|
872-50-4
|
Toxic for reproduction (Article 57c) |
8th recommendation
|
Recommended for inclusion in Annex XIV
|
05-velj-2018
|
Details | |
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
EC No.:
272-013-1
| CAS No.:
68648-93-1
|
-
|
-
|
Toxic for reproduction (Article 57c) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details |
246-677-8
|
25155-23-1
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details | |
235-380-9
|
12202-17-4
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
231-556-4
|
7632-04-4
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details | |
show/hide
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)
EC No.:
-
| CAS No.:
125022-34-6
|
-
|
-
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details |
235-067-7
|
12065-90-6
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
215-235-6
|
1314-41-6
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
215-267-0
|
1317-36-8
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
7th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
10-stu-2016
|
Details |
201-559-5
|
84-75-3
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details | |
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
7th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
10-stu-2016
|
Details |